Intensified Rituximab Induction Followed By Rituximab Maintenance For Low Grade B Cell Lymphoma: A Multicenter, Phase II Study

被引：0
|
作者：
Yamada, Kyouhei
Sawamura, Mario
Shimomura, Takeshi
Takeuchi, Makoto
Hanada, Shuichi
Komeno, Takuya
Hidaka, Michihiro
Yano, Takahiro
Kitano, Kiyoshi
Yoshida, Isao
Inoue, Nobumasa
Horibe, Keizo
Tomoyuki, Watanabe
Sunami, Kazutaka
Nagai, Hirokazu
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1797.1797
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1797
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Treatment of low-grade B-cell lymphoma with the monoclonal antibody rituximab
    Dillman, RO
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 434 - 447
  • [22] A Pilot Study of Acalabrutinib With Bendamustine/Rituximab Followed by Cytarabine/Rituximab for Untreated Mantle Cell Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (04) : 12 - 12
  • [23] BENDAMUSTINE WITH RITUXIMAB FOR RELAPSED OR REFRACTORY LOW-GRADE B-CELL LYMPHOMA
    Oda, H.
    Ikeda, M.
    Choi, I.
    Suehiro, Y.
    Abe, Y.
    Uike, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 106 - 106
  • [24] Rituximab plus CHOP followed by maintenance rituximab as initial therapy for advanced stage indolent non-Hodgkin's lymphoma (NHL); Initial results of induction therapy in a phase II study.
    Huang, JE
    Hart, L
    Polikoff, J
    Langmuir, V
    Zhang, F
    Fehrenbacher, L
    BLOOD, 2004, 104 (11) : 237B - 237B
  • [25] Multicenter phase II study of rituximab-ABVD in classic Hodgkin lymphoma (cHL)
    Kasamon, Y. L.
    Jacene, H. A.
    Swinnen, L. J.
    Popplewell, L.
    Link, B. K.
    Habermann, T. M.
    Herman, J. M.
    Jones, R. J.
    Ambinder, R. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] IELSG-38: A Phase II Study of Chlorambucil in Combination with Rituximab Followed By Maintenance Therapy with Subcutaneous Rituximab in Patients with Extranodal Marginal Zone B-Cell Lymphoma of Mucosa Associated Lymphoid Tissue (MALT)
    Stathis, Anastasios
    Gregorini, Anna
    Gressin, Remy
    Orsucci, Lorella
    Perrot, Aurore
    Tani, Monica
    Coiffier, Bertrand
    Musuraca, Gerardo
    Guieze, Romain
    Marino, Dario
    Gini, Guido
    Ferrari, Angela
    Gyan, Emmanuel
    Morschhauser, Franck
    Palombi, Francesca
    Cavallo, Federica
    Le Gouill, Steven
    Tilly, Herve
    Salvi, Flavia
    Conconi, Annarita
    Cabras, Maria Giuseppina
    Capochiani, Enrico
    Califano, Catello
    Molinari, Anna Lia
    Pulsoni, Alessandro
    Ielmini, Nicoletta
    Luminari, Stefano
    Cavalli, Franco
    Zucca, Emanuele
    Thieblemont, Catherine
    BLOOD, 2017, 130
  • [27] Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab: A multicenter phase II study
    Tobinai, Kensei
    Igarashi, Tadahiko
    Itoh, Kuniaki
    Kurosawa, Mitsutoshi
    Nagai, Hirokazu
    Hiraoka, Akira
    Kinoshita, Tomohiro
    Uike, Naokuni
    Ogura, Michinori
    Nawano, Shigeru
    Mori, Shigeo
    Ohashi, Yasuo
    CANCER SCIENCE, 2011, 102 (09) : 1698 - 1705
  • [28] Phase II Study of Zanubrutinib in Combination with Rituximab and Methotrexate, Followed By Zanubrutinib Maintenance in Patients with Secondary Central Nervous System Lymphoma
    Deng, Lijuan
    He, Tianheng
    Mei, Di
    Tang, Yongjing
    Lu, Changyu
    Zhang, Xian
    Zhang, Meixiang
    Chen, Feng
    Wang, Xiaopei
    Zhu, Jun
    Song, Yuqin
    BLOOD, 2022, 140 : 9459 - 9460
  • [29] A Phase II Trial of Bendamustine, Bortezomib, and Rituximab in Patients with Previously Untreated Low Grade Lymphoma
    Flinn, Ian W.
    Ervin, Thomas J.
    Boccia, Ralph V.
    Flora, Douglas B.
    Cuevas, J. Daniel
    Thompson, Dana S.
    Shipley, Dianna L.
    Berdeja, Jesus G.
    BLOOD, 2015, 126 (23)
  • [30] Lenalidomide and Rituximab Regimen Combined With Intravitreal Methotrexate Followed by Lenalidomide Maintenance for Primary Vitreoretinal Lymphoma: A Prospective Phase II Study
    Zhang, Yan
    Zhang, Xiao
    Zou, Dongmei
    Yin, Jingjing
    Zhang, Li
    Wang, Xuan
    Jia, Congwei
    Wang, Wei
    Zhao, Danqing
    Zhou, Daobin
    Zhang, Wei
    Zhang, Meifen
    FRONTIERS IN ONCOLOGY, 2021, 11
12345